Related Experiment Videos
Thiol-modifying inhibitors for understanding squalene cyclase function
Paola Milla1, Alexander Lenhart, Giorgio Grosa
1Università degli Studi di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Torino, Italy.
European Journal of Biochemistry
|May 3, 2002
Summary
Investigating Alicyclobacillus acidocaldarius squalene-hopene cyclase reveals that modifying cysteine residue C435 obstructs the substrate access channel. This finding clarifies enzyme function and substrate interaction mechanisms.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Squalene-hopene cyclase (SHC) is crucial for synthesizing hopanoids, essential membrane components in many bacteria.
- Understanding the precise mechanism of substrate access and catalysis in SHC is vital for elucidating bacterial lipid biosynthesis.
Purpose of the Study:
- To investigate the role of specific cysteine residues in the function of squalene-hopene cyclase from Alicyclobacillus acidocaldarius.
- To determine how substrate access to the active site is regulated and identify key residues involved in this process.
Main Methods:
- Site-directed mutagenesis was used to create mutants with altered cysteine residues.
- Thiol-reacting molecules and squalene analogues were employed as labeling agents and inhibitors.
- Liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) was used to analyze modified enzyme fragments.
Main Results:
- Cysteine residue C435, located at a constriction in the substrate access channel, was identified as critical for enzyme function.
- Labeling experiments demonstrated that C435 is covalently modified by squalene-like inhibitors.
- Modification of C435 led to time-dependent inactivation of the enzyme, suggesting obstruction of the substrate channel.
Conclusions:
- Cysteine 435 plays a pivotal role in regulating substrate entry into the active site of squalene-hopene cyclase.
- The findings provide insights into the structural and functional importance of the nonpolar channel and its constriction.
- Targeting C435 with specific inhibitors offers a potential strategy for modulating SHC activity.